Purple BiotechPPBT
13F holders, Q3 2024 (September 30)1holders −20
0new positions
13sold out
$5.53avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Purple Biotech Ltd. (PPBT) in their 13F filings, down 20 from Q2 2024. 0 opened new positions and 13 sold out. The largest holder was North Star Investment Management Corp. ($83).
- Company
- Purple Biotech Ltd.
- CUSIP
- 74638P109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 13 | $137K |
All 13F filers, Q2 2024 → Q3 2024: 338,809 shares sold, net −338,809 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| North Star Investment Management Corp. | 0.00% | Reduce -95.0% | 15 | $83 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd. the manager owns.